Compounds > 1-(3-c-ethynylribopentofuranosyl)uracil
Page last updated: 2024-12-08
1-(3-c-ethynylribopentofuranosyl)uracil
Description
1-(3-C-ethynylribopentofuranosyl)uracil is a **synthetic nucleoside analog**, also known as **3'-ethynyl-2'-deoxyuridine (EdU)**.
**Here's a breakdown:**
* **Nucleoside analog:** It's a modified version of a natural nucleoside, in this case, uridine.
* **Uridine:** A nucleoside found in RNA, composed of uracil base attached to a ribose sugar.
* **3'-ethynylribopentofuranosyl:** This describes the modified sugar part of the molecule. 3'-ethynyl means a carbon-carbon triple bond (ethynyl) is attached to the third carbon (3') of the ribose sugar. ribopentofuranosyl refers to the ribose sugar in its furanose form (a five-membered ring structure).
**Why is EdU important for research?**
EdU is a powerful tool for **cell proliferation studies**. It is used in **click chemistry**, a technique that allows for the selective and rapid reaction between two molecules.
Here's how it works:
1. **Cell Incorporation:** Cells actively dividing incorporate EdU into their newly synthesized DNA during S phase (DNA replication).
2. **Click Chemistry:** A special reagent containing an azide group is added to the cells. The ethynyl group on EdU reacts specifically with the azide group, forming a stable covalent bond. This reaction is known as the click reaction.
3. **Detection and Quantification:** The reaction product can be visualized and quantified using various techniques, such as fluorescence microscopy or flow cytometry. This allows researchers to track and measure DNA replication in cells.
**Research Applications of EdU:**
* **Cancer research:** Studying the proliferation and growth of cancer cells.
* **Developmental biology:** Investigating cell division and differentiation during embryonic development.
* **Neuroscience:** Understanding the generation of new neurons in the brain.
* **Stem cell research:** Analyzing the proliferative potential of stem cells.
* **Drug discovery:** Screening for potential anti-proliferative agents.
**Advantages of EdU over other methods:**
* **High sensitivity:** EdU is very sensitive, allowing for the detection of even low levels of DNA replication.
* **Fast reaction:** The click reaction is rapid and efficient, providing quick results.
* **Compatibility:** EdU is compatible with various imaging techniques and cell fixation methods.
**In summary,** 1-(3-C-ethynylribopentofuranosyl)uracil, or EdU, is a valuable tool for researchers studying cell proliferation and DNA replication. Its unique chemical properties allow for sensitive and efficient detection of actively dividing cells, making it a crucial element in diverse research areas.
1-(3-C-ethynylribopentofuranosyl)uracil: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 176869 |
SCHEMBL ID | 1650289 |
MeSH ID | M0269626 |
Synonyms (13)
Synonym |
2,4(1h,3h)-pyrimidinedione, 1-(3-c-ethynyl-.beta.-d-ribofuranosyl)- |
eurd |
1-[(2r,3r,4s,5r)-4-ethynyl-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione |
3'-c-ethynyluridine |
1-(3'-c-ethynyl-beta-d-ribofuranosyl)uracil |
1-(3-c-ethynylribopentofuranosyl)uracil |
uridine, 3'-c-ethynyl |
3-c-ethynyl-uridine |
pj-272 |
pj 272 |
180300-49-6 |
SCHEMBL1650289 |
DTXSID30170947 |
Research
Studies (10)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (50.00) | 18.2507 |
2000's | 3 (30.00) | 29.6817 |
2010's | 2 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 11.86
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 11.86 (24.57) | Research Supply Index | 2.48 (2.92) | Research Growth Index | 4.34 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (9.09%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 10 (90.91%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |